"Immunotherapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.
| Descriptor ID |
D007167
|
| MeSH Number(s) |
E02.095.465.425
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunotherapy".
Below are MeSH descriptors whose meaning is more specific than "Immunotherapy".
This graph shows the total number of publications written about "Immunotherapy" by people in this website by year, and whether "Immunotherapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 3 | 3 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 1 | 2 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 3 | 2 | 5 |
| 2006 | 1 | 2 | 3 |
| 2007 | 2 | 1 | 3 |
| 2008 | 0 | 2 | 2 |
| 2009 | 2 | 2 | 4 |
| 2010 | 5 | 2 | 7 |
| 2011 | 3 | 0 | 3 |
| 2012 | 1 | 5 | 6 |
| 2013 | 3 | 2 | 5 |
| 2014 | 0 | 2 | 2 |
| 2015 | 5 | 1 | 6 |
| 2016 | 6 | 5 | 11 |
| 2017 | 2 | 3 | 5 |
| 2018 | 4 | 4 | 8 |
| 2019 | 7 | 5 | 12 |
| 2020 | 4 | 6 | 10 |
| 2021 | 7 | 8 | 15 |
| 2022 | 3 | 13 | 16 |
| 2023 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunotherapy" by people in Profiles.
-
An Update on Clinical Trials and Potential Therapeutic Strategies in T-Cell Acute Lymphoblastic Leukemia. Int J Mol Sci. 2023 Apr 13; 24(8).
-
Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistance. Cell Rep. 2023 04 25; 42(4):112314.
-
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma. BMC Cancer. 2023 Mar 23; 23(1):265.
-
Stress-Mediated Attenuation of Translation Undermines T-cell Activity in Cancer. Cancer Res. 2022 12 02; 82(23):4386-4399.
-
Vaccination-based immunotherapy to target profibrotic cells in liver and lung. Cell Stem Cell. 2022 10 06; 29(10):1459-1474.e9.
-
Monitoring Therapeutic Responses to Silicified Cancer Cell Immunotherapy Using PET/MRI in a Mouse Model of Disseminated Ovarian Cancer. Int J Mol Sci. 2022 Sep 10; 23(18).
-
Complement downregulation promotes an inflammatory signature that renders colorectal cancer susceptible to immunotherapy. J Immunother Cancer. 2022 09; 10(9).
-
Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence. J Hematol Oncol. 2022 06 11; 15(1):80.
-
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021. J Transl Med. 2022 06 07; 20(1):257.
-
Impact of concomitant fibrates on immunotherapy outcomes for advanced non-small cell lung cancer. Cancer Med. 2023 01; 12(1):358-367.